proguanil hydrochloride
proguanil hydrochloride.JPG

CLINICAL USE

Malaria chemoprophylaxis

DOSE IN NORMAL RENAL FUNCTION

200 mg daily

PHARMACOKINETICS

  • Molecular weight                           :290.2
  • %Protein binding                           :75
  • %Excreted unchanged in urine     : 60
  • Volume of distribution (L/kg)       :No data
  • half-life – normal/ESRD (hrs)      :20

    DOSE IN RENAL IMPAIRMENT

    GFR (mL/MIN)

    20–60 100 mg daily
  • 10 to 20     : 50 mg every 48 hours
  • <10           : 50 mg weekly

    DOSE IN PATIENTS UNDERGOING RENAL REPLACEMENT THERAPIES

  • CAPD                :Unlikely to be dialysed. Dose as in GFR <10 mL/min
  • HD                     :Not dialysed. Dose as in GFR <10 mL/min
  • HDF/high flux   :Unknown dialysability. Dose as in GFR <10 mL/min
  • CAV/VVHD      :Unknown dialysability. Dose as in GFR 10 to 20 mL/min

    IMPORTANT DRUG INTERACTIONS

    Potentially hazardous interactions with other drugs
  • Anticoagulants: effect of warfarin possibly enhanced
  • Antimalarials: avoid concomitant use with artemether/lumefantrine; increased antifolate effect with pyrimethamine

    ADMINISTRATION

    Reconstition

    Route

    Oral

    Rate of Administration

    Comments

    OTHER INFORMATION

    Rare reports of haematological changes (e.g. megaloblastic anaemia and pancytopenia) in patients with severe renal impairment



    See how to identify renal failure stages according to GFR calculation

    See how to diagnose irreversible renal disease

    Home

  • other drugs